PubMed
open access
Pharmaceutical Industry Payments to Patient Groups in Australia: A Longitudinal Analysis of a Decade of Disclosures.
To analyse the extent and patterns of pharmaceutical industry funding of patient groups in Australia between 2013 and 2022, including the proportion of groups' income derived from industry payments in 2022.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The role of digital pharmaceutical governance in alleviating health inequality: a case study of the “Sanya Model” for centralized regional prescription review.#251126
- Evolution of community pharmacy services in the European Union and beyond: a cross-country survey of 33 national pharmacy organisations.#375357
- Pharmaceutical Public-Private Partnerships in the United States and Europe: Moving from the Bench to the Bedside#271038
- Impact of Clinical Pharmacy Service on Patient Care and Cost Saving#828184
- Exploring alternative funding mechanisms to improve patient access to innovative medicines.#160060
Record · ID 1221465
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive